{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:47:04Z","timestamp":1782402424938,"version":"3.54.5"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004206","name":"The University of Osaka","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00595-026-03267-3","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:39:10Z","timestamp":1773920350000},"page":"1075-1083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress in immunological research on innate effectors in xenotransplantation"],"prefix":"10.1007","volume":"56","author":[{"given":"Shuji","family":"Miyagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyoshi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Kogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"3267_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/00007890-198812000-00007","volume":"46","author":"S Miyagawa","year":"1988","unstructured":"Miyagawa S, Hirose H, Shirakura R, Naka Y, Nakata S, Kawashima Y, et al. The mechanism of discordant xenograft rejection. Transplantation. 1988;46:825\u201330.","journal-title":"Transplantation"},{"key":"3267_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1399-3089.2010.00569.x","volume":"17","author":"S Miyagawa","year":"2010","unstructured":"Miyagawa S, Yamamoto A, Matsunami K, Wang D, Takama Y, Ueno T, et al. Complement regulation in the GalT KO era. Xenotransplantation. 2010;17:11\u201325.","journal-title":"Xenotransplantation"},{"key":"3267_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/00007890-199109000-00029","volume":"52","author":"AP Dalmasso","year":"1991","unstructured":"Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation. 1991;52:530\u20133.","journal-title":"Transplantation"},{"key":"3267_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm0995-964","volume":"1","author":"E Cozzi","year":"1995","unstructured":"Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med. 1995;1:964\u20136.","journal-title":"Nat Med"},{"key":"3267_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1399-3089.2003.00103_11_2.x","volume":"11","author":"BE Loveland","year":"2004","unstructured":"Loveland BE, Milland J, Kyriakou P, Thorley BR, Christiansen D, Lanteri MB, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation. 2004;11:171\u201383.","journal-title":"Xenotransplantation"},{"key":"3267_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1399-3089.2006.00368.x","volume":"14","author":"PJ Cowan","year":"2007","unstructured":"Cowan PJ. Coagulation and the xenograft endothelium. Xenotransplantation. 2007;14:7\u201312.","journal-title":"Xenotransplantation"},{"key":"3267_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/glycob\/cwt088","volume":"24","author":"S Miyagawa","year":"2014","unstructured":"Miyagawa S, Maeda A, Kawamura T, Ueno T, Usui N, Kondo S, et al. A comparison of the main structures of N-glycans of porcine islets with those from humans. Glycobiology. 2014;24:125\u201338.","journal-title":"Glycobiology"},{"key":"3267_CR8","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","volume":"88","author":"U Galili","year":"1991","unstructured":"Galili U, Swanson K. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci U S A. 1991;88:7401\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3267_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1399-0012.1992.tb00614.x","volume":"6","author":"DKC Cooper","year":"1992","unstructured":"Cooper DKC. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in humans. Clin Transplant. 1992;6:178\u201383.","journal-title":"Clin Transplant"},{"key":"3267_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nm1295-1261","volume":"1","author":"MS Sandrin","year":"1995","unstructured":"Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med. 1995;1:1261\u20137.","journal-title":"Nat Med"},{"key":"3267_CR11","doi-asserted-by":"publisher","first-page":"16421","DOI":"10.1074\/jbc.273.26.16421","volume":"273","author":"M Tanemura","year":"1998","unstructured":"Tanemura M, Miyagawa S, Koyota S, Koma M, Matsuda H, Tsuji S, et al. Reduction of the major swine xenoantigen, the alpha-galactosyl epitope by transfection of the alpha2,3-sialyltransferase gene. J Biol Chem. 1998;273:16421\u20135.","journal-title":"J Biol Chem"},{"key":"3267_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/glycob\/10.7.745","volume":"10","author":"M Koma","year":"2000","unstructured":"Koma M, Miyagawa S, Honke K, Ikeda Y, Koyota S, Miyoshi S, et al. Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases. Glycobiology. 2000;10:745\u201351.","journal-title":"Glycobiology"},{"key":"3267_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/bbrc.1997.6784","volume":"235","author":"M Tanemura","year":"1997","unstructured":"Tanemura M, Miyagawa S, Ihara Y, Matsuda H, Shirakura R, Taniguchi N. Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection. Biochem Biophys Res Commun. 1997;235:359\u201364.","journal-title":"Biochem Biophys Res Commun"},{"key":"3267_CR14","doi-asserted-by":"publisher","first-page":"39310","DOI":"10.1074\/jbc.M104359200","volume":"276","author":"S Miyagawa","year":"2001","unstructured":"Miyagawa S, Murakami H, Takahagi Y, Nakai R, Yamada M, Murase A, et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem. 2001;276:39310\u20139.","journal-title":"J Biol Chem"},{"key":"3267_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/mrd.20305","volume":"71","author":"Y Takahagi","year":"2005","unstructured":"Takahagi Y, Fujimura T, Miyagawa S, Nagashima H, Shigehisa T, Shirakura R, et al. Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev. 2005;71:331\u20138.","journal-title":"Mol Reprod Dev"},{"key":"3267_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1399-3089.2005.00206.x","volume":"12","author":"H Komoda","year":"2005","unstructured":"Komoda H, Miyagawa S, Omori T, Takahagi Y, Murakami H, Shigehisa T, et al. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys. Xenotransplantation. 2005;12:209\u201316.","journal-title":"Xenotransplantation"},{"key":"3267_CR17","doi-asserted-by":"publisher","first-page":"19368","DOI":"10.1074\/jbc.M001888200","volume":"275","author":"H Ogawa","year":"2000","unstructured":"Ogawa H, Muramatsu H, Kobayashi T, Morozumi K, Yokoyama I, Kurosawa N, et al. Molecular cloning of endo-beta -galactosidase C and its application in removing alpha -galactosyl xenoantigen from blood vessels in the pig kidney. J Biol Chem. 2000;275:19368\u201374.","journal-title":"J Biol Chem"},{"key":"3267_CR18","doi-asserted-by":"crossref","unstructured":"Miyagawa S. Xenotransplantation and glycomedicine. Comprehensive Glycoscience. Johannis P Kamerling, editors ELSEVIER Press. 2007;533\u2009\u2013\u200953.","DOI":"10.1016\/B978-044451967-2\/00113-6"},{"key":"3267_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nbt0302-251","volume":"20","author":"Y Dai","year":"2002","unstructured":"Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol. 2002;20:251\u20135.","journal-title":"Nat Biotechnol"},{"key":"3267_CR20","doi-asserted-by":"publisher","first-page":"15866","DOI":"10.1074\/jbc.273.25.15866","volume":"273","author":"A Irie","year":"1998","unstructured":"Irie A, Koyama S, Kozutsumi Y, Kawasaki T, Suzuki A. The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem. 1998;273:15866\u201371.","journal-title":"J Biol Chem"},{"key":"3267_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/xen.12019","volume":"20","author":"AJ Lutz","year":"2013","unstructured":"Lutz AJ, Li P, Estrada JL, Sidner RA, Chihara RK, Downey SM. Double knockout pigs deficient in N-glycolylneuraminic acid and galactose alpha-1,3-galactose reduce the humoral barrier to xenotransplantation. Xenotransplantation. 2013;20:27\u201335.","journal-title":"Xenotransplantation"},{"key":"3267_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1262\/jrd.2015-058","volume":"61","author":"S Miyagawa","year":"2015","unstructured":"Miyagawa S, Matsunari H, Watanabe M, Nakano K, Umeyama K, Sakai R, et al. Generation of \u03b11,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs. J Reprod Dev. 2015;61:449\u201357.","journal-title":"J Reprod Dev"},{"key":"3267_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/xen.12124","volume":"21","author":"GW Byrne","year":"2014","unstructured":"Byrne GW, Du Z, Stalboerger P, Kogelberg H, McGregor CGA. Cloning and expression of porcine \u03b21,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen. Xenotransplantation. 2014;21:543\u201354.","journal-title":"Xenotransplantation"},{"key":"3267_CR24","doi-asserted-by":"crossref","unstructured":"Lo PC, Eguchi H, Sakai R, Maeda A, Kogata S, Toyama C et al. Reaction to the porcine cells with or without b4GalNT2. Transplant Proc. 2020;52:1916-8.","DOI":"10.1016\/j.transproceed.2020.01.154"},{"key":"3267_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1399-3089.2011.00674.x","volume":"18","author":"B Petersen","year":"2011","unstructured":"Petersen B, Ramackers W, Lucas-Hahn A, Lemme E, Hassel P, Queisser AL, et al. Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys. Xenotransplantation. 2011;18:355\u201368.","journal-title":"Xenotransplantation"},{"key":"3267_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1399-3089.2009.00556.x","volume":"16","author":"M Oropeza","year":"2009","unstructured":"Oropeza M, Petersen B, Carnwath JW, Lucas-Hahn A, Lemme E, Hassel P, et al. Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation. 2009;16:522\u201334.","journal-title":"Xenotransplantation"},{"key":"3267_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00007890-199807150-00016","volume":"66","author":"S Yun","year":"1998","unstructured":"Yun S, Gustafsson K, Fabre JW. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Transplantation. 1998;66:103\u201311.","journal-title":"Transplantation"},{"key":"3267_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/imm.12107","volume":"140","author":"H Hara","year":"2013","unstructured":"Hara H, Witt W, Crossley T, Long C, Isse K, Fan L, et al. <article-title update=\u201cadded\u201d> Human dominant\u2010negative class <scp>II<\/scp> transactivator transgenic pigs\u00a0\u2013 effect on the human anti\u2010pig <scp>T<\/scp> \u2010cell immune response and immune status. Immunology. 2013;140:39\u201346.","journal-title":"Immunology"},{"key":"3267_CR29","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.4049\/jimmunol.1402059","volume":"193","author":"LM Reyes","year":"2014","unstructured":"Reyes LM, Estrada JL, Wang ZY, Blosser RJ, Smith RF, Sidner RA, et al. <article-title update=\u201cadded\u201d>Creating class I MHC\u2013null pigs using guide RNA and the Cas9 endonuclease. J Immunol. 2014;193:5751\u20137.","journal-title":"J Immunol"},{"key":"3267_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11248-013-9780-x","volume":"23","author":"SJ Park","year":"2014","unstructured":"Park SJ, Cho B, Koo OJ, Koo OJ, Kim H, Kang JT, et al. Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide. Transgenic Res. 2014;23:407\u201319.","journal-title":"Transgenic Res"},{"key":"3267_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(23)00775-4","volume":"402","author":"MM Mohiuddin","year":"2023","unstructured":"Mohiuddin MM, Singh AK, Scobie L, Goerlich CE, Grazioli A, Saharia K, et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet. 2023;402:397\u2013410.","journal-title":"Lancet"},{"key":"3267_CR32","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa2412747","volume":"392","author":"T Kawai","year":"2025","unstructured":"Kawai T, Williams WW, Elias N, Fishman JA, Crisalli K, Longchamp A, et al. Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease. N Engl J Med. 2025;392:1933\u201340.","journal-title":"N Engl J Med"},{"key":"3267_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2201422","volume":"387","author":"BP Griffith","year":"2022","unstructured":"Griffith BP, Goerlich CE, Singh AK, Rothblatt M, Lau CL, Shah A, et al. Genetically modified porcine-to-human cardiac xenotransplantation. N Engl J Med. 2022;387:35\u201344.","journal-title":"N Engl J Med"},{"key":"3267_CR34","first-page":"1","volume":"0","author":"T Hirose","year":"2025","unstructured":"Hirose T, Hotta K, Kawai T. Current progress in kidney xenotransplantation: time to proceed to clinical trials. Int J Urol. 2025;0:1\u201310.","journal-title":"Int J Urol"},{"key":"3267_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47454-7","volume":"15","author":"MD Cheung","year":"2024","unstructured":"Cheung MD, Asiimwe R, Erman EN, Fucile CF, Liu S, Sun CW, et al. Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplant. Nat Commun. 2024;15:3140.","journal-title":"Nat Commun"},{"key":"3267_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.125.074971","author":"A Giarraputo","year":"2025","unstructured":"Giarraputo A, Morgand E, Stern J, Mezine F, Coutance G, Goutaudier V, et al. Characterizing the immune response in pig-to-human heart xenograftsusing a multimodal diagnostic system. Circulation. 2025. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074971.","journal-title":"Circulation"},{"key":"3267_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4627384","volume":"2017","author":"G Puga Yung","year":"2017","unstructured":"Puga Yung G, Schneider MKJ, Seebach JD. The role of NK cells in pig-to-human xenotransplantation. J Immunol Res. 2017;2017:4627384.","journal-title":"J Immunol Res"},{"key":"3267_CR38","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/xen.70037","volume":"32","author":"GL Puga Yung","year":"2025","unstructured":"Puga Yung GL, Wakley T, Kouklas A, Seebach JD. Dendritic cells in xenotransplantation: shaping the cellular immune response toward tolerance. Xenotransplantation. 2025;32:e70037.","journal-title":"Xenotransplantation"},{"key":"3267_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233865","volume":"11","author":"TY Lu","year":"2022","unstructured":"Lu TY, Xu XL, Du XG, Wei JH, Yu JN, Deng SL, et al. Advances in innate immunity to overcome immune rejection during xenotransplantation. Cells. 2022;11:3865.","journal-title":"Cells"},{"key":"3267_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1189\/jlb.0904494","volume":"78","author":"F Al-Mohanna","year":"2005","unstructured":"Al-Mohanna F, Saleh S, Parhar RS, Khabar K, Collison K. Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed. J Leukoc Biol. 2005;78:51\u201361.","journal-title":"J Leukoc Biol"},{"key":"3267_CR41","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1073\/pnas.0609661104","volume":"104","author":"K Ide","year":"2007","unstructured":"Ide K, Wang H, Tahara H, Liu J, Wang X, Asahara T, et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A. 2007;104:5062\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3267_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00000658-196409000-00006","volume":"160","author":"K Reemtsma","year":"1964","unstructured":"Reemtsma K, McCracken BH, Schlegel JU, Pearl MA, Pearce CW, Dewitt CW, et al. Renal heterotransplantation in man. Ann Surg. 1964;160:384\u2013410.","journal-title":"Ann Surg"},{"key":"3267_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0022-1759(84)90045-0","volume":"73","author":"CW Vogel","year":"1984","unstructured":"Vogel CW, M\u00fcller-Eberhard HJ. Cobra venom factor: improved method for purification and biochemical characterization. J Immunol Methods. 1984;73:203\u201320.","journal-title":"J Immunol Methods"},{"key":"3267_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00007890-199304000-00004","volume":"55","author":"S Miyagawa","year":"1993","unstructured":"Miyagawa S, Shirakura R, Matsumiya G, Fukushima N, Nakata S, Matsuda H, et al. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175. Transplantation. 1993;55:709\u201313.","journal-title":"Transplantation"},{"key":"3267_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1126\/science.2371562","volume":"249","author":"HF Weisman","year":"1990","unstructured":"Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990;249:146\u201351.","journal-title":"Science"},{"key":"3267_CR46","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.bjp.0706286","volume":"145","author":"DG Souza","year":"2005","unstructured":"Souza DG, Esser D, Bradford R, Vieira AT, Teixeira MM. APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol. 2005;145:1027\u201334.","journal-title":"Br J Pharmacol"},{"key":"3267_CR47","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","volume":"334","author":"AT Waytes","year":"1996","unstructured":"Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med. 1996;334:1630\u20134.","journal-title":"N Engl J Med"},{"key":"3267_CR48","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","volume":"33","author":"TC Thomas","year":"1996","unstructured":"Thomas TC, Rollins SA, Rother RP, Giannoni MA, Hartman SL, Elliott EA, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain. Fv Mol Immunol. 1996;33:1389\u2013401.","journal-title":"Fv Mol Immunol"},{"key":"3267_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","volume":"9","author":"JE Locke","year":"2009","unstructured":"Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, et al. The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transpl. 2009;9:231\u20135.","journal-title":"Am J Transpl"},{"key":"3267_CR50","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.4049\/jimmunol.158.6.2872","volume":"158","author":"PJ Higgins","year":"1997","unstructured":"Higgins PJ, Ko JL, Lobell R, Sardonini C, Alessi MK, Yeh CG. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J Immunol. 1997;158:2872\u201381.","journal-title":"J Immunol"},{"key":"3267_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/pro.5560070311","volume":"7","author":"D Morikis","year":"1998","unstructured":"Morikis D, Assa-Munt N, Sahu A, Lambris JD. Solution structure of Compstatin, a potent complement inhibitor. Protein Sci. 1998;7:619\u201327.","journal-title":"Protein Sci"},{"key":"3267_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1348-0421.2007.tb03918.x","volume":"51","author":"N Okada","year":"2007","unstructured":"Okada N, Asai S, Hotta A, Miura N, Ohno N, Farkas I, et al. Increased inhibitory capacity of an anti-C5a complementary peptide following acetylation of N-terminal alanine. Microbiol Immunol. 2007;51:439\u201343.","journal-title":"Microbiol Immunol"},{"key":"3267_CR53","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1182\/blood.2019003399","volume":"135","author":"A R\u00f6th","year":"2020","unstructured":"R\u00f6th A, Nishimura JI, Nagy Z, Ga\u00e0l-Weisinger J, Panse J, Yoon SS, et al. The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria. Blood. 2020;135:912\u201320.","journal-title":"Blood"},{"key":"3267_CR54","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41590-019-0503-1","volume":"20","author":"DC Mastellos","year":"2019","unstructured":"Mastellos DC, Blom AM, Connolly ES, Daha MR, Geisbrecht BV, Ghebrehiwet B, et al. \u201cStealth\u201d corporate innovation: an emerging threat for therapeutic drug development. Nat Immunol. 2019;20:1409\u201313.","journal-title":"Nat Immunol"},{"key":"3267_CR55","doi-asserted-by":"crossref","unstructured":"Risitano AM, R\u00f6th A, Soret J, Frieri C, de Fontbrune FS, Marano L et al. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Lancet Haematol. 202;8:e344-e354.","DOI":"10.1016\/S2352-3026(21)00028-4"},{"issue":"Suppl 2","key":"3267_CR56","doi-asserted-by":"publisher","first-page":"ii28","DOI":"10.1093\/ckj\/sfad198","volume":"16","author":"F Caravaca-Font\u00e1n","year":"2023","unstructured":"Caravaca-Font\u00e1n F, Guti\u00e9rrez E, Sevillano \u00c1M, Praga M. Targeting complement in IgA nephropathy. Clin Kidney J. 2023;16(Suppl 2):ii28\u201339.","journal-title":"Clin Kidney J"},{"key":"3267_CR57","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1172\/JCI16526","volume":"110","author":"AG Katopodis","year":"2002","unstructured":"Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, et al. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer. J Clin Invest. 2002;110:1869\u201377.","journal-title":"J Clin Invest"},{"key":"3267_CR58","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1097\/00007890-200206150-00014","volume":"73","author":"LE Diamond","year":"2002","unstructured":"Diamond LE, Byrne GW, Schwarz A, Davis TA, Adams DH, Logan JS. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation. 2002;73:1780\u20137.","journal-title":"Transplantation"},{"key":"3267_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12296","volume":"24","author":"H Iwase","year":"2017","unstructured":"Iwase H, Liu H, Li T, Zhang Z, Gao B, Hara H, et al. Therapeutic regulation of systemic inflammation in xenograft recipients. Xenotransplantation. 2017;24:10.1111\/xen.12296.","journal-title":"Xenotransplantation"},{"key":"3267_CR60","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1084\/jem.166.5.1280","volume":"166","author":"PF Piguet","year":"1987","unstructured":"Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor\/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med. 1987;166:1280\u20139.","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"3267_CR61","doi-asserted-by":"publisher","first-page":"S660","DOI":"10.1111\/j.1432-2277.1994.tb01467.x","volume":"7","author":"RL Marquet","year":"1994","unstructured":"Marquet RL, Bonthuis F, van Iijken M, Bouwman E, Wolvekamp MC, van Rooijen N, et al. Primary nonfunction of islet xenografts: the role of macrophages. Transpl Int. 1994;7(Suppl 1):S660-2.","journal-title":"Transpl Int"},{"key":"3267_CR62","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.imbio.2019.04.003","volume":"224","author":"PC Lo","year":"2019","unstructured":"Lo PC, Maeda A, Kodama T, Takakura C, Yoneyama T, Sakai R, et al. The novel immunosuppressant prenylated quinolinecarboxylic acid-18 (PQA-18) suppresses macrophage differentiation and cytotoxicity in xenotransplantation. Immunobiology. 2019;224:575\u201384.","journal-title":"Immunobiology"},{"key":"3267_CR63","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.tp.0000168151.83816.f4","volume":"80","author":"S Hayashi","year":"2005","unstructured":"Hayashi S, Leu D, Yamii Y, Mei G, Takagi H, Nakao A. Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation. Transplantation. 2005;80:494\u20139.","journal-title":"Transplantation"},{"key":"3267_CR64","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/intimm\/dxh162","volume":"16","author":"JL Ferrant","year":"2004","unstructured":"Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, et al. The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. Int Immunol. 2004;16:1583\u201394.","journal-title":"Int Immunol"},{"key":"3267_CR65","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.ajt.2023.03.025","volume":"23","author":"S Miura","year":"2023","unstructured":"Miura S, Habibabady ZA, Pollok F, Ma M, Rosales IA, Kinoshita K, et al. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival. Am J Transplant. 2023;23:1182\u201393.","journal-title":"Am J Transplant"},{"key":"3267_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf6376","volume":"15","author":"IJ Anwar","year":"2023","unstructured":"Anwar IJ, Berman DM, DeLaura I, Gao Q, Willman MA, Miller A, et al. The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates. Sci Transl Med. 2023;15:eadf6376.","journal-title":"Sci Transl Med"},{"key":"3267_CR67","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3727\/000000002783985440","volume":"11","author":"B Benda","year":"2002","unstructured":"Benda B, Ljunggren HG, Peach R, Sandberg JO, Korsgren O. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice. Cell Transpl. 2002;11:715\u201320.","journal-title":"Cell Transpl"},{"key":"3267_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1034\/j.1399-3089.2001.008003157.x","volume":"8","author":"IP Alwayn","year":"2001","unstructured":"Alwayn IP, Xu Y, Basker M, Wu C, Buhler L, Lambrigts D. Effects of specific anti-B and\/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation. 2001;8:157\u201371.","journal-title":"Xenotransplantation"},{"key":"3267_CR69","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1111\/xen.70003","volume":"32","author":"RPH Meier","year":"2025","unstructured":"Meier RPH, Pierson RN 3rd, Fishman JA, Buhler LH, Bottino R, Ladowski JM, et al. International xenotransplantation association (IXA) position paper on kidney xenotransplantation. Xenotransplantation. 2025;32:e70003.","journal-title":"Xenotransplantation"},{"key":"3267_CR70","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa2412747","volume":"392","author":"T Kawai","year":"2025","unstructured":"Kawai T, Williams WW, Elias N, Fishman JA, Crisalli K, Longchamp A, et al. Xenotransplantation of a porcine kidney for end-stage kidney disease. N Engl J Med. 2025;392:1933\u201340.","journal-title":"N Engl J Med"},{"key":"3267_CR71","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/00007890-199705150-00021","volume":"63","author":"L Inverardi","year":"1997","unstructured":"Inverardi L, Clissi B, Stolzer AL, Bender JR, Sandrin MS, Pardi R. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation. 1997;63:1318\u201330.","journal-title":"Transplantation"},{"key":"3267_CR72","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/oxfordjournals.jbchem.a022551","volume":"126","author":"S Miyagawa","year":"1999","unstructured":"Miyagawa S, Nakai R, Yamada M, Tanemura M, Ikeda Y, Taniguchi N, et al. Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen. J Biochem. 1999;126:1067\u201373.","journal-title":"J Biochem"},{"key":"3267_CR73","doi-asserted-by":"publisher","first-page":"10717","DOI":"10.1074\/jbc.274.16.10717","volume":"274","author":"JH Artrip","year":"1999","unstructured":"Artrip JH, Kwiatkowski P, Michler RE, Wang SF, Tugulea S, Ankersmit J, et al. Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase. J Biol Chem. 1999;274:10717\u201322.","journal-title":"J Biol Chem"},{"key":"3267_CR74","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.TP.0000157231.11083.7C","volume":"79","author":"BC Baumann","year":"2005","unstructured":"Baumann BC, Schneider MK, Lilienfeld BG, Antsiferova MA, Rhyner DM, Hawley RJ, et al. Endothelial cells derived from pigs lacking Gal alpha(1,3)Gal: no reduction of human leukocyte adhesion and natural killer cell cytotoxicity. Transplantation. 2005;79:1067\u201372.","journal-title":"Transplantation"},{"key":"3267_CR75","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1399-3089.2006.00332.x","volume":"13","author":"D Christiansen","year":"2006","unstructured":"Christiansen D, Mouhtouris E, Milland J, Zingoni A, Santoni A, Sandrin MS. Recognition of a carbohydrate xenoepitope by human NKRP1A (CD161). Xenotransplantation. 2006;13:440\u20136.","journal-title":"Xenotransplantation"},{"key":"3267_CR76","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.4049\/jimmunol.173.6.3945","volume":"173","author":"S Miyagawa","year":"2004","unstructured":"Miyagawa S, Kubo T, Matsunami K, Kusama T, Beppu K, Nozaki H, et al. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis. J Immunol. 2004;173:3945\u201352.","journal-title":"J Immunol"},{"key":"3267_CR77","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.4049\/jimmunol.163.11.6301","volume":"163","author":"H Sasaki","year":"1999","unstructured":"Sasaki H, Xu XC, Mohanakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94\/NKG2-dependent and -independent pathways. J Immunol. 1999;163:6301\u20135.","journal-title":"J Immunol"},{"key":"3267_CR78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1365-2249.2001.01622.x","volume":"126","author":"K Matsunami","year":"2001","unstructured":"Matsunami K, Miyagawa S, Nakai R, Murase A, Shirakura R. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis. Clin Exp Immunol. 2001;126:165\u201372.","journal-title":"Clin Exp Immunol"},{"key":"3267_CR79","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/00007890-200205270-00010","volume":"73","author":"K Matsunami","year":"2002","unstructured":"Matsunami K, Miyagawa S, Nakai R, Yamada M, Shirakura R. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis. Transplantation. 2002;73:1582\u20139.","journal-title":"Transplantation"},{"key":"3267_CR80","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.bbrc.2006.06.146","volume":"347","author":"K Matsunami","year":"2006","unstructured":"Matsunami K, Kusama T, Okura E, Shirakura R, Fukuzawa M, Miyagawa S. Involvement of position-147 for HLA-E expression. Biochem Biophys Res Commun. 2006;347:692\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"3267_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trim.2013.08.001","volume":"29","author":"A Maeda","year":"2013","unstructured":"Maeda A, Kawamura T, Ueno T, Usui N, Eguchi H, Miyagawa S. The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E. Transpl Immunol. 2013;29:76\u201381.","journal-title":"Transpl Immunol"},{"key":"3267_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.trim.2014.12.004","volume":"32","author":"EL Esquivel","year":"2015","unstructured":"Esquivel EL, Maeda A, Eguchi H, Asada M, Sugiyama M, Manabe C, et al. Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G. Transpl Immunol. 2015;32:109\u201315.","journal-title":"Transpl Immunol"},{"key":"3267_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858604","volume":"13","author":"A Maeda","year":"2022","unstructured":"Maeda A, Kogata S, Toyama C, Lo PC, Okamatsu C, Yamamoto R, et al. The innate cellular immune response in xenotransplantation. Front Immunol. 2022;13:858604.","journal-title":"Front Immunol"},{"key":"3267_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860165","volume":"13","author":"S Miyagawa","year":"2022","unstructured":"Miyagawa S, Maeda A, Toyama C, Kogata S, Okamatsu C, Yamamoto R, et al. Aspects of the complement system in new era of xenotransplantation. Front Immunol. 2022;13:860165.","journal-title":"Front Immunol"},{"key":"3267_CR85","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.4049\/jimmunol.163.9.5039","volume":"163","author":"M Matsumoto","year":"1999","unstructured":"Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, et al. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol. 1999;163:5039\u201348.","journal-title":"J Immunol"},{"key":"3267_CR86","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molmed.2005.06.008","volume":"11","author":"JH Meyers","year":"2005","unstructured":"Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med. 2005;11:362\u20139.","journal-title":"Trends Mol Med"},{"key":"3267_CR87","first-page":"162","volume":"9","author":"R Hanayama","year":"2006","unstructured":"Hanayama R, Miyasaka K, Nakaya M, Nagata S. MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure. Curr Dir Autoimmun. 2006;9:162\u201372.","journal-title":"Curr Dir Autoimmun"},{"key":"3267_CR88","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1189\/jlb.0904494","volume":"78","author":"F Al-Mohanna","year":"2005","unstructured":"Al-Mohanna F, Saleh S, Parhar RS, Khabar K, Collison K. Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed. J Leukoc Biol. 2005;78:51\u201361.","journal-title":"J Leukoc Biol"},{"key":"3267_CR89","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/SHK.0000000000000044","volume":"40","author":"ZV Schofield","year":"2013","unstructured":"Schofield ZV, Woodruff TM, Halai M, Wu MC, Cooper MA. Neutrophils\u2014a key component of ischemia-reperfusion injury. Shock. 2013;40:463\u201370.","journal-title":"Shock"},{"key":"3267_CR90","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.4049\/jimmunol.1300601","volume":"191","author":"SM Saleh","year":"2013","unstructured":"Saleh SM, Parhar RS, Al-Hejailan RS, Bakheet RH, Khaleel HS, Khalak HG, et al. Idtification of the tetraspanin CD82 as a new barrier to xenotransplantation. J Immunol. 2013;191:2796\u2013805.","journal-title":"J Immunol"},{"key":"3267_CR91","first-page":"292","volume":"10","author":"K Takase","year":"2025","unstructured":"Takase K, Gadomska K, Maeda A, Matsu J, Nakahata K, Nomura M, et al. HLA-Class Ib Expression Suppresses Neutrophil Xenogeneic Immune Responses Against Pig Cells. J Clin Exp Nephrol. 2025;10:292.","journal-title":"J Clin Exp Nephrol"},{"key":"3267_CR92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200839","volume":"218","author":"T Deuse","year":"2021","unstructured":"Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, et al. The SIRP\u03b1-CD47 immune checkpoint in NK cells. J Exp Med. 2021;218:e20200839.","journal-title":"J Exp Med"},{"key":"3267_CR93","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","volume":"288","author":"PA Oldenborg","year":"2000","unstructured":"Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288:2051\u20134.","journal-title":"Science"},{"key":"3267_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-019-00469-5","volume":"43","author":"SMG Hayat","year":"2020","unstructured":"Hayat SMG, Bianconi V, Pirro M, Jaafari MR, Hatamipour M, Sahebkar A. CD47: role in the immune system and application to cancer therapy. Cell Oncol (Dordr). 2020;43:19\u201330.","journal-title":"Cell Oncol (Dordr)"},{"key":"3267_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12459","volume":"26","author":"M Chen","year":"2019","unstructured":"Chen M, Wang Y, Wang H, Sun L, Fu Y, Yang YG. Elimination of donor CD47 protects against vascularized allograft rejection in mice. Xenotransplantation. 2019;26:e12459.","journal-title":"Xenotransplantation"},{"key":"3267_CR96","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12708","volume":"28","author":"K Takeuchi","year":"2021","unstructured":"Takeuchi K, Ariyoshi Y, Shimizu A, Okumura Y, Cara-Fuentes G, Garcia GE, et al. Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation. Xenotransplantation. 2021;28:e12708.","journal-title":"Xenotransplantation"},{"key":"3267_CR97","doi-asserted-by":"publisher","first-page":"e12549","DOI":"10.1111\/xen.12549","volume":"27","author":"S Nomura","year":"2020","unstructured":"Nomura S, Ariyoshi Y, Watanabe H, Pomposelli T, Takeuchi K, Garcia G, et al. Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages. Xenotransplantation. 2020;27:e12549.","journal-title":"Xenotransplantation"},{"key":"3267_CR98","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1172\/JCI25461","volume":"115","author":"CV Thakar","year":"2005","unstructured":"Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest. 2005;115:3451\u20139.","journal-title":"J Clin Invest"},{"key":"3267_CR99","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/joneph\/20.5.588","volume":"20","author":"S Lario","year":"2007","unstructured":"Lario S, Besc\u00f3s M, Campos B, Mur C, Luque P, Alvarez R, et al. Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors. J Nephrol. 2007;20:588\u201395.","journal-title":"J Nephrol"},{"key":"3267_CR100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(03)00758-X","volume":"115","author":"SJ Gardai","year":"2003","unstructured":"Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, et al. By binding SIRPalpha or calreticulin\/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 2003;115:13\u201323.","journal-title":"Cell"},{"key":"3267_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1164\/rccm.200711-1661oc","volume":"178","author":"WJ Janssen","year":"2008","unstructured":"Janssen WJ, McPhillips KA, Dickinson MG, Linderman DJ, Morimoto K, Xiao YQ, et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med. 2008;178:158\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"3267_CR102","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trim.2018.02.003","volume":"47","author":"P Jiaravuthisan","year":"2018","unstructured":"Jiaravuthisan P, Maeda A, Takakura C, Wang HT, Sakai R, Mohd Shabri A, et al. A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells. Transpl Immunol. 2018;47:44\u20138.","journal-title":"Transpl Immunol"},{"key":"3267_CR103","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11527","volume":"24","author":"C Toyama","year":"2022","unstructured":"Toyama C, Maeda A, Kogata S, Yamamoto R, Masahata K, Ueno T, et al. Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A. Exp Ther Med. 2022;24:590.","journal-title":"Exp Ther Med"},{"key":"3267_CR104","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/493945","volume":"2012","author":"K Ohtani","year":"2012","unstructured":"Ohtani K, Suzuki Y, Wakamiya N. Biological functions of the novel collectins CL-L1, CL-K1, and CL-P1. J Biomed Biotechnol. 2012;2012:493945.","journal-title":"J Biomed Biotechnol"},{"key":"3267_CR105","doi-asserted-by":"publisher","first-page":"19386","DOI":"10.1074\/jbc.M111.324533","volume":"287","author":"B Fournier","year":"2012","unstructured":"Fournier B, Andargachew R, Robin AZ, Laur O, Voelker DR, Lee WY, et al. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein alpha (SIRPalpha), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein beta (SIRPbeta). J Biol Chem. 2012;287:19386\u201398.","journal-title":"J Biol Chem"},{"key":"3267_CR106","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4049\/jimmunol.2100266","volume":"207","author":"L Shi","year":"2021","unstructured":"Shi L, Bian Z, Kidder K, Liang H, Liu Y. Non-lyn Src family kinases activate SIRP\u03b1\u2013SHP-1 to inhibit PI3K\u2013Akt2 and dampen proinflammatory macrophage polarization. J Immunol. 2021;207:1419\u201327.","journal-title":"J Immunol"},{"key":"3267_CR107","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00595-017-1546-2","volume":"48","author":"R Sakai","year":"2018","unstructured":"Sakai R, Maeda A, Choi TV, Lo PC, Jiaravuthiasan P, Shabri AM, et al. Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis. Surg Today. 2018;48:119\u201326.","journal-title":"Surg Today"},{"key":"3267_CR108","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.imbio.2019.07.008","volume":"224","author":"Y Noguchi","year":"2019","unstructured":"Noguchi Y, Maeda A, Lo PC, Takakura C, Haneda T, Kodama T, et al. Human TIGIT on porcine aortic endothelial cells suppresses xenogeneic macrophage-mediated cytotoxicity. Immunobiology. 2019;224:605\u201313.","journal-title":"Immunobiology"},{"key":"3267_CR109","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/xen.12067","volume":"21","author":"A Maeda","year":"2014","unstructured":"Maeda A, Kawamura T, Ueno T, Usui N, Miyagawa S. Monocytic suppressor cells derived from human peripheral blood suppress xenogenic immune reaction. Xenotransplantation. 2014;21:46\u201356.","journal-title":"Xenotransplantation"},{"key":"3267_CR110","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.transproceed.2013.11.026","volume":"46","author":"A Maeda","year":"2014","unstructured":"Maeda A, Kawamura T, Nakahata K, Ueno T, Usui N, Hiroshi H, et al. Regulation of macrophage-mediated xenocytotoxicity by overexpression of alpha 2,6-sialyltransferase in swine endothelial cells. Transplant Proc. 2014;46:1256\u20138.","journal-title":"Transplant Proc"},{"key":"3267_CR111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.trim.2015.07.002","volume":"33","author":"A Maeda","year":"2015","unstructured":"Maeda A, Eguchi H, Nakahta K, Lo PC, Yamanaka K, Kawamura T, et al. Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity. Transpl Immunol. 2015;33:140\u20135.","journal-title":"Transpl Immunol"},{"key":"3267_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102020","volume":"84","author":"K Iemitsu","year":"2024","unstructured":"Iemitsu K, Sakai R, Maeda A, Gadomska K, Kogata S, Yasufuku D, et al. The hybrid CL-SP-D molecule has the potential to regulate xenogeneic rejection by human neutrophils more efficiently than CD47. Transpl Immunol. 2024;84:102020.","journal-title":"Transpl Immunol"},{"key":"3267_CR113","doi-asserted-by":"publisher","first-page":"20555","DOI":"10.1074\/jbc.272.33.20555","volume":"272","author":"JP Newton","year":"1997","unstructured":"Newton JP, Buckley CD, Jones EY, Simmons DL. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1\/CD31. J Biol Chem. 1997;272:20555\u201363.","journal-title":"J Biol Chem"},{"key":"3267_CR114","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol P, Liao D, Mei H, Hu Y, Newman PJ. Endothelial functions of platelet\/endothelial cell adhesion molecule-1(CD31). Curr Opin Hematol. 2016;23:253\u20139.","journal-title":"Curr Opin Hematol"},{"key":"3267_CR115","doi-asserted-by":"publisher","first-page":"23603","DOI":"10.1074\/jbc.M701120200","volume":"282","author":"UJH Sachs","year":"2007","unstructured":"Sachs UJH, Andrei-Selmer CL, Maniar A, Weiss T, Paddock C, Orlova VV, et al. The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem. 2007;282:23603\u201312.","journal-title":"J Biol Chem"},{"key":"3267_CR116","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.transproceed.2020.01.140","volume":"52","author":"Y Noguchi","year":"2020","unstructured":"Noguchi Y, Maeda A, Wang HT, Takakura C, Lo PC, Kodama T, et al. Human CD31 on Swine endothelial cells induces SHP-1 phosphorylation in macrophages. Transplant Proc. 2020;52:1913\u20135.","journal-title":"Transplant Proc"},{"key":"3267_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101663","volume":"74","author":"S Kogata","year":"2022","unstructured":"Kogata S, Lo PC, Maeda A, Okamatsu C, Sato K, Yamamoto R, et al. Suppression of macrophage-mediated xenogeneic rejection by the ectopic expression of human CD177. Transpl Immunol. 2022;74:101663.","journal-title":"Transpl Immunol"},{"key":"3267_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/xen.12396","volume":"25","author":"HT Wang","year":"2018","unstructured":"Wang HT, Maeda A, Sakai R, Lo PC, Takakura C, Jiaravuthisan P, et al. Human CD31 on porcine cells suppress xenogeneic neutrophil-mediated cytotoxicity via the inhibition of NETosis. Xenotransplantation. 2018;25:e12396.","journal-title":"Xenotransplantation"},{"key":"3267_CR119","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001175","volume":"7","author":"T Yoneyama","year":"2021","unstructured":"Yoneyama T, Maeda A, Kogata S, Toyama C, Lo PC, Masahata K, et al. The regulation of neutrophil extracellular trap-induced tissue damage by human CD177. Transplant Direct. 2021;7:e734.","journal-title":"Transplant Direct"},{"key":"3267_CR120","doi-asserted-by":"crossref","unstructured":"Miyagawa S, Maeda A, Matsunami K, Eguchi H, Okuyama H. Aiming for the clinical application of xenotransplantation. In: Heart and lung transplantation: historical developments, clinical achievements, and future perspectives. Springer Singapore; 2025. p. 277\u201389.","DOI":"10.1007\/978-981-96-8810-4_24"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03267-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03267-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:02:38Z","timestamp":1782399758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03267-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":120,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3267"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03267-3","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Acknowledgements section has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to declare in association with the present review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}